Citation Impact
Citing Papers
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
2002
Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis
2002
Sterically Stabilized Anti-HER2 Immunoliposomes: Design and Targeting to Human Breast Cancer Cells in Vitro
1997
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
2012
Tipin-Replication Protein A Interaction Mediates Chk1 Phosphorylation by ATR in Response to Genotoxic Stress
2010 StandoutNobel
HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells
2005
G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
2008
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Colloidal drug carriers: achievements and perspectives
2003
Ligand-targeted liposomal anticancer drugs
2003
A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
2016
Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers
2003
Hydrogels in Regenerative Medicine
2009 Standout
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel
2003
Polymer-coated long-circulating microparticulate pharmaceuticals
1998
Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation
2012
The DNA Damage Response Kinases DNA-dependent Protein Kinase (DNA-PK) and Ataxia Telangiectasia Mutated (ATM) Are Stimulated by Bulky Adduct-containing DNA
2011 StandoutNobel
Distal Cationic Poly(Ethylene Glycol) Lipid Conjugates in Large Unilamellar Vesicles Prepared by Extrusion Enhance Liposomal Cellular Uptake
2004
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor
2011
Challenges in Development of Targeted Liposomal Therapeutics
2012
Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin
2007
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer
2001
In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach
2001
Enhancement of the in vivo circulation lifetime of l-α-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization
1997
Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes
2002
Recent advances in stealth coating of nanoparticle drug delivery systems
2012
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs
1999
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Cancer nanotechnology: opportunities and challenges
2005 Standout
Delivery of c-myb Antisense Oligodeoxynucleotides to Human Neuroblastoma Cells Via Disialoganglioside GD2-Targeted Immunoliposomes: Antitumor Effects
2000
In vivo cancer targeting and imaging with semiconductor quantum dots
2004 Standout
Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts
2007
The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)
2011
The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes
2014
The golden age: gold nanoparticles for biomedicine
2011 Standout
Ba/F3 cells and their use in kinase drug discovery
2006
Evaluation of Blood Clearance Rates and Biodistribution of Poly(2-oxazoline)-Grafted Liposomes§
1996
Natural Product Hybrids as New Leads for Drug Discovery
2003 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Amphiphilic poly-N-vinylpyrrolidones:
2001
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Recent developments in the field of antitumour anthracyclines
2001
Targeting DNA repair mechanisms in cancer
2012
Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis
2002
Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes
1997
CASK Functions as a Mg2+-Independent Neurexin Kinase
2008 StandoutNobel
Ligand-targeted therapeutics in anticancer therapy
2002
A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis
2015
Structure and design of polymeric surfactant-based drug delivery systems
2001
Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer
2004
Nanofabricated particles for engineered drug therapies: A preliminary biodistribution study of PRINT™ nanoparticles
2007
Trigger release liposome systems: local and remote controlled delivery?
2011
CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells
2004
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicin
2000
Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications
2009 Standout
Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein
2001
Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application
2007 Standout
Understanding biophysicochemical interactions at the nano–bio interface
2009 Standout
Parameters influencing the stealthiness of colloidal drug delivery systems
2006
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells
2001
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
2009
Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
2007 Standout
New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network
2010
Impact of Nanotechnology on Drug Delivery
2009 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Antitumor activity of an epithelial cell adhesion molecule–targeted nanovesicular drug delivery system
2007
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
2008
Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes
2012 StandoutNobel
Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
2003
Liposomes: Applications in Medicine
2001
Physical−Chemical Aspects of Protein Corona: Relevance toin Vitroandin VivoBiological Impacts of Nanoparticles
2011 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
2018
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Shrink-Wrap Vesicles
2005 StandoutNobel
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
2003
The effect of particle design on cellular internalization pathways
2008 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors
2005
Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
2003
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
1998
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Poly(ethylene glycol)-Grafted Liposomes with Oligopeptide or Oligosaccharide Ligands Appended to the Termini of the Polymer Chains
1997
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
2008 Standout
Nanoparticles with targeting, triggered release, and imaging functionality for cancer applications
2010
Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs.
2002
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
2011 Standout
Aggregation Behavior of Poly(ethylene glycol-bl-propylene sulfide) Di- and Triblock Copolymers in Aqueous Solution
2009 StandoutNobel
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Generation of Superparamagnetic Liposomes Revealed as Highly Efficient MRI Contrast Agents for in Vivo Imaging
2005
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Preparation of PEG-grafted immunomagnetoliposomes entrapping citrate stabilized magnetite particles and their application in CD34+ cell sorting
2001
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
1999
A distinct subpopulation of CD25−T-follicular regulatory cells localizes in the germinal centers
2017 StandoutNobel
Works of Daniel E. Lopes de Menezes being referenced
CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo
2007
Combined treatment of Bcl‐2 antisense oligodeoxynucleotides (G3139), p‐glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug‐resistant growth of drug‐resistant breast cancer in severely combined immunodeficient mice
2003
Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo
2000
Recombinant Interleukin-2 Significantly Augments Activity of Rituximab in Human Tumor Xenograft Models of B-cell Non-Hodgkin Lymphoma
2006
Immunoliposome-mediated targeting of anti-cancer drugs in vivo
1995
CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia
2005
Cellular Trafficking and Cytotoxicity of Anti-Cd19-Targeted Liposomal Doxorubicin in B Lymphoma Cells
1999
Long-circulating, polyethylene glycol-grafted immunoliposomes
1996
Pharmacokinetics of long-circulating liposomes
1995